China NT Pharma Group (HKG:1011) entered into a non-legally binding memorandum of understanding with Shanxi Ningle Pharmaceutical Logistics regarding potential cooperation between the parties related to the company's products and services in the field of orthopedics, a Monday filing with the Hong Kong Exchange said.
The company plans to make some rapid expansion in orthopedics through this cooperation.
The company's shares were down over 5% on Tuesday's close.
Price (HKD): $0.27, Change: $-0.02, Percent Change: -5.26%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments